Common Contracts
2 similar Purchase Agreement contracts by Integra Lifesciences Holdings Corp, Penson Worldwide Inc
INTEGRA LIFESCIENCES HOLDINGS CORPORATION Purchase AgreementPurchase Agreement • June 15th, 2011 • Integra Lifesciences Holdings Corp • Laboratory analytical instruments • New York
Integra LifeSciences Holdings Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representatives (the “Representatives”), $200,000,000 principal amount of its 1.625% Convertible Senior Notes due 2016 (the “Underwritten Securities”) and, at the option of the Initial Purchasers, up to an additional $30,000,000 principal amount of its 1.625% Convertible Senior Notes due 2016 (the “Option Securities”) solely to cover over-allotments, if and to the extent that the Initial Purchasers shall have determined to exercise the option to purchase such 1.625% Convertible Senior Notes due 2016 granted to the Initial Purchasers in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities”. The Securities will be convertible into cash or a combination of cash and shares (the “Underlying Securities”) of c
PENSON WORLDWIDE, INC. Purchase AgreementPurchase Agreement • May 29th, 2009 • Penson Worldwide Inc • Security brokers, dealers & flotation companies • New York
Penson Worldwide, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to J.P. Morgan Securities Inc. and Morgan Keegan & Company, Inc. (the “Initial Purchasers”), as listed in Schedule 1 hereto, $50,000,000 principal amount of its 8.0% Convertible Senior Notes due 2014 (the “Firm Securities”). The Firm Securities will be issued pursuant to an Indenture to be dated as of June 3, 2009 (the “Indenture”) among the Company and U.S. Bank National Association, as trustee (the “Trustee”). The Company also proposes to issue and sell to the Initial Purchasers not more than an additional $10,000,000 principal amount of its 8.0% Convertible Senior Notes due 2014 (the “Additional Securities”) if and to the extent that the Initial Purchaser shall have determined to exercise the right to purchase such Additional Securities granted to the Initial Purchasers in Section 1 hereof. The Firm Securities and the Additional Securities are hereinafter collectively referred to as the “Secur
